JENNIFER SUMMERS: Open Payments
NPI 1386284123 · HARLAN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$207 in 10 payments from 7 companies in 2025. Trend: 2023 $44 · 2024 $118 · 2025 $207
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: ARISTADA, COBENFY, Auvelity, CAPLYTA, HETLIOZ, UZEDY, SPRAVATO.
Industry payments across KY — which companies pay providers there.
